The diagnostic status of chronic kidney disease in a real-world database in Japan: CHECK-CKD

Toshiki Moriyama1, Keigo Kanafuri2, Mayu Kanno2

  • 1Health and Counseling Center, Osaka University, 1-17, Machikaneyama-cho, Toyonaka-shi, Osaka, 560-0043, Japan. toshiki.moriyama@gmail.com.

Insights

Chronic kidney disease (CKD) diagnosis rates in Japan remained low despite guidelines. Early detection through periodic blood and urine tests is crucial for managing CKD and preventing complications.

Area of Science:

  • Nephrology
  • Public Health
  • Epidemiology

Background:

  • CKD management in Japan was expected to improve following 2018 guidelines and 2021 therapeutic agent launch.
  • The actual status of CKD diagnosis rates and management remains unclear.
  • This study investigates CKD diagnosis trends and outcomes in Japan.

Purpose of the Study:

  • To evaluate changes in CKD diagnosis rates from 2014 to 2023.
  • To identify factors associated with CKD diagnosis.
  • To assess the prognostic impact of CKD diagnosis timing on cardiorenal events.

Main Methods:

  • Retrospective observational study using administrative claims and medical checkup data (2014-2023).
  • Inclusion criteria: patients with potential CKD risk (eGFR < 60 mL/min/1.73 m² and/or urine protein ≥1+).
  • Analysis of CKD diagnosis rates, patient characteristics, and cardiorenal event incidence.

Main Results:

  • Approximately 3% of patients newly met CKD diagnostic criteria annually until 2021.
  • CKD diagnosis was associated with blood/urine tests, anemia, heart failure, and diabetes.
  • Incidence of cardiorenal events at 36 months was 4.5% for stage 3a and 12.4% for stage 3b CKD.

Conclusions:

  • The prevalence of CKD diagnosis in Japan is low, with infrequent renal function testing.
  • Early detection of CKD through regular blood and urine tests is recommended.
  • Timely diagnosis and management are critical for improving patient outcomes and reducing cardiorenal events.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
573
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
346
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
559
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
191
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
322
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
271